| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.00086 | 1 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.0008 | 1 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | -0.00079 | 1 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.00067 | 1 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.00058 | 1 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.00049 | 1 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.00041 | 1 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.00047 | 1 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.00032 | 1 |